Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo

Authors:

Abstract
No abstract available
Funding Information
  • Icahn School of Medicine at Mount Sinai
  • Baylor College of Medicine
  • University of California, San Diego
  • Bristol-Myers Squibb
  • University of Cincinnati
  • Daiichi-Sankyo
  • University of Chicago
  • Shire
  • Roche
  • Temple University
  • Gilead Sciences
  • Cedars-Sinai Medical Center
  • AbbVie
  • Bayer Fund
  • University of Pennsylvania
  • Prometheus
  • Novartis
  • School of Medicine, Indiana University
  • Merck

This publication has 19 references indexed in Scilit: